Kantarjian, H.M.;                     Zugmaier, G.;                     Brüggemann, M.;                     Wood, B.L.;                     Horst, H.A.;                     Zeng, Y.;                     Martinelli, G.    
        Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers 2021, 13, 5607.
    https://doi.org/10.3390/cancers13225607
    AMA Style
    
                                Kantarjian HM,                                 Zugmaier G,                                 Brüggemann M,                                 Wood BL,                                 Horst HA,                                 Zeng Y,                                 Martinelli G.        
                Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers. 2021; 13(22):5607.
        https://doi.org/10.3390/cancers13225607
    
    Chicago/Turabian Style
    
                                Kantarjian, Hagop M.,                                 Gerhard Zugmaier,                                 Monika Brüggemann,                                 Brent L. Wood,                                 Heinz A. Horst,                                 Yi Zeng,                                 and Giovanni Martinelli.        
                2021. "Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia" Cancers 13, no. 22: 5607.
        https://doi.org/10.3390/cancers13225607
    
    APA Style
    
                                Kantarjian, H. M.,                                 Zugmaier, G.,                                 Brüggemann, M.,                                 Wood, B. L.,                                 Horst, H. A.,                                 Zeng, Y.,                                 & Martinelli, G.        
        
        (2021). Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Cancers, 13(22), 5607.
        https://doi.org/10.3390/cancers13225607